| # | Drug | Count |
|---|---|---|
| 0 | RELUGOLIX | 39 |
| 1 | ERGOCALCIFEROL | 16 |
| 2 | ACETAMINOPHEN | 14 |
| 3 | ATORVASTATIN CALCIUM | 11 |
| 4 | ASPIRIN | 10 |
| 5 | ASPIRIN 325 MG | 10 |
| 6 | ASPIRIN 81 MG | 10 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 9 |
| 8 | ENZALUTAMIDE | 9 |
| 9 | ATORVASTATIN CALCIUM, FILM COATED | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM ANTACID | 1 | 0.0023 |
| 1 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 2 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 3 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 4 | QUERCETIN | 1 | 0.0008 |
| 5 | NERANDOMILAST | 1 | 0.0006 |
| 6 | TALAZOPARIB | 1 | 0.0005 |
| 7 | ERGOCALCIFEROL | 16 | 0.0005 |
| 8 | PHENAZOPYRIDINE | 2 | 0.0005 |
| 9 | ZURANOLONE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 39 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 2 | Provitamin D2 Compound [EPC] | 16 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 5 | Corticosteroid [EPC] | 10 |
| 6 | Expectorant [EPC] | 10 |
| 7 | Androgen Receptor Inhibitor [EPC] | 9 |
| 8 | Vitamin C [EPC] | 9 |
| 9 | Benzodiazepine [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 39 | 0.0015 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 3 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 1 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 6 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Anti-anginal [EPC] | 2 | 0.0002 |
| 8 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Androgen Receptor Inhibitor [EPC] | 9 | 0.0001 |